Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9347820rdf:typepubmed:Citationlld:pubmed
pubmed-article:9347820lifeskim:mentionsumls-concept:C0032285lld:lifeskim
pubmed-article:9347820lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:9347820lifeskim:mentionsumls-concept:C1332717lld:lifeskim
pubmed-article:9347820lifeskim:mentionsumls-concept:C1706438lld:lifeskim
pubmed-article:9347820lifeskim:mentionsumls-concept:C0024264lld:lifeskim
pubmed-article:9347820lifeskim:mentionsumls-concept:C0085358lld:lifeskim
pubmed-article:9347820lifeskim:mentionsumls-concept:C0056855lld:lifeskim
pubmed-article:9347820lifeskim:mentionsumls-concept:C1413244lld:lifeskim
pubmed-article:9347820lifeskim:mentionsumls-concept:C2698600lld:lifeskim
pubmed-article:9347820pubmed:issue10lld:pubmed
pubmed-article:9347820pubmed:dateCreated1997-11-18lld:pubmed
pubmed-article:9347820pubmed:abstractTextA large number of drugs can induce pulmonary disease. We report the case of a female patient who was receiving cyproterone acetate for severe hirsutism. After 4 months of cyproterone therapy, she had dyspnea, pulmonary infiltrates, and a restrictive ventilatory defect. Bronchoalveolar lavage showed CD8+ lymphocytosis as well as increased neutrophils and eosinophils, a profile highly suggestive of an iatrogenic process. The patient showed no other significant clinical or biologic abnormality. Symptoms and functional abnormalities disappeared after withdrawal of cyproterone and reappeared after its reintroduction. This suggests that cyproterone acetate, a substance used to treat hirsutism and prostate cancer and in the composition of certain oral contraceptives, can be added to the list of drugs that may cause lymphocytic pneumonitis.lld:pubmed
pubmed-article:9347820pubmed:languageenglld:pubmed
pubmed-article:9347820pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9347820pubmed:citationSubsetAIMlld:pubmed
pubmed-article:9347820pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9347820pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9347820pubmed:statusMEDLINElld:pubmed
pubmed-article:9347820pubmed:monthOctlld:pubmed
pubmed-article:9347820pubmed:issn0038-4348lld:pubmed
pubmed-article:9347820pubmed:authorpubmed-author:DerenneJ PJPlld:pubmed
pubmed-article:9347820pubmed:authorpubmed-author:OrcelBBlld:pubmed
pubmed-article:9347820pubmed:authorpubmed-author:SimilowskiTTlld:pubmed
pubmed-article:9347820pubmed:issnTypePrintlld:pubmed
pubmed-article:9347820pubmed:volume90lld:pubmed
pubmed-article:9347820pubmed:ownerNLMlld:pubmed
pubmed-article:9347820pubmed:authorsCompleteYlld:pubmed
pubmed-article:9347820pubmed:pagination1048-9lld:pubmed
pubmed-article:9347820pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:9347820pubmed:meshHeadingpubmed-meshheading:9347820-...lld:pubmed
pubmed-article:9347820pubmed:meshHeadingpubmed-meshheading:9347820-...lld:pubmed
pubmed-article:9347820pubmed:meshHeadingpubmed-meshheading:9347820-...lld:pubmed
pubmed-article:9347820pubmed:meshHeadingpubmed-meshheading:9347820-...lld:pubmed
pubmed-article:9347820pubmed:meshHeadingpubmed-meshheading:9347820-...lld:pubmed
pubmed-article:9347820pubmed:meshHeadingpubmed-meshheading:9347820-...lld:pubmed
pubmed-article:9347820pubmed:meshHeadingpubmed-meshheading:9347820-...lld:pubmed
pubmed-article:9347820pubmed:meshHeadingpubmed-meshheading:9347820-...lld:pubmed
pubmed-article:9347820pubmed:meshHeadingpubmed-meshheading:9347820-...lld:pubmed
pubmed-article:9347820pubmed:year1997lld:pubmed
pubmed-article:9347820pubmed:articleTitleCD8+ lymphocytic pneumonitis in a patient receiving cyproterone acetate.lld:pubmed
pubmed-article:9347820pubmed:affiliationService de Pneumologie et Réanimation, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.lld:pubmed
pubmed-article:9347820pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9347820pubmed:publicationTypeCase Reportslld:pubmed